Latest Period
Q2 2026
Security Snapshot
Apyx Medical Corp - Common Stock (APYX) Institutional Ownership
CUSIP: 03837C106
13F Institutional Holders and Ownership History from Q4 2018 to Q2 2026
Institutions Reporting
68
Shares (Excl. Options)
21,305,178
Price
$4.49
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- APYX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 21,305,178
- Total 13F value
- $95,653,830
- Portfolio coverage rank
- 0%
- Share change
- +495,402
- Value change
- +$2,373,825
- Number of holders
- 68
- Shares outstanding
- 41,921,434
- SEC-reported price per share
- $4.49
- Insider filing price
- $4.49
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- APYX - Apyx Medical Corp - Common Stock is tracked under CUSIP 03837C106.
- 68 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 67 to 68 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $76,784,547 to $95,653,830.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 68 institutions filings for Q2 2026.
Security key
03837C106
Latest holder period
Q2 2026
13F holders
68
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
APYX full holder history
Apyx Medical Corp SEC filings
Apyx Medical Corp company facts
Apyx Medical Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03837C106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
APYX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10% | 0% | $14,394,468 | +$2,168,145 | 4,112,705 | +18% | Nantahala Capital Management, LLC | 31 Dec 2025 |
| ROYCE & ASSOCIATES LP | 7.8% | +31% | $14,700,547 | +$3,731,320 | 3,274,064 | +34% | ROYCE & ASSOCIATES LP | 30 Jun 2026 |
As of 30 Jun 2026, 68 institutional investors reported holding 21,305,178 shares of Apyx Medical Corp - Common Stock (APYX). This represents 51% of the company’s total 41,921,434 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
48%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ROYCE & ASSOCIATES LP | 7.8% | 3,274,064 | +25% | 0.12% | $14,700,547 |
| Nantahala Capital Management, LLC | 7.8% | 3,270,248 | -4.9% | 0.89% | $14,683,414 |
| Archon Capital Management LLC | 6.3% | 2,644,717 | -5.2% | 4.8% | $11,874,779 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 1,534,847 | -1.3% | 0% | $6,891,463 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 2.7% | 1,136,630 | +26% | 0.67% | $5,103,469 |
| AIGH Capital Management LLC | 2.7% | 1,128,343 | +2.1% | 0.46% | $5,066,260 |
| Silverberg Bernstein Capital Management LLC | 2.5% | 1,039,641 | -0.14% | 1.8% | $4,667,988 |
| COMMONWEALTH EQUITY SERVICES, LLC | 1.5% | 649,061 | 0% | 0% | $2,914,280 |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 1.4% | 585,000 | -4.9% | 0.03% | $2,626,650 |
| BlackRock, Inc. | 1.3% | 560,986 | +6.3% | 0% | $2,518,828 |
| RENAISSANCE TECHNOLOGIES LLC | 1.3% | 554,278 | +83% | 0% | $2,488,708 |
| Taylor Frigon Capital Management LLC | 0.99% | 413,602 | -0.23% | 0.87% | $1,857,073 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.96% | 400,600 | +2.4% | 0% | $1,799,895 |
| Legato Capital Management LLC | 0.91% | 382,762 | +36% | 0.14% | $1,718,601 |
| SEI INVESTMENTS CO | 0.67% | 281,029 | -53% | 0% | $1,261,820 |
| Huntleigh Advisors, Inc. | 0.63% | 263,231 | +7% | 0.17% | $1,181,906 |
| MILLENNIUM MANAGEMENT LLC | 0.58% | 242,663 | -7.4% | 0% | $1,089,557 |
| MARSHALL WACE, LLP | 0.56% | 236,466 | +282% | 0% | $1,061,732 |
| VANGUARD FIDUCIARY TRUST CO | 0.53% | 224,021 | +11% | 0% | $1,005,854 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.52% | 216,263 | -19% | 0% | $971,021 |
| Kingsview Wealth Management, LLC | 0.51% | 214,288 | +2.6% | 0.01% | $962,153 |
| Caption Management, LLC | 0.44% | 183,003 | -1.5% | 0.03% | $821,683 |
| Hillsdale Investment Management Inc. | 0.44% | 182,600 | +4.8% | 0.02% | $819,874 |
| Informed Momentum Co LLC | 0.41% | 170,470 | -31% | 0.07% | $765,410 |
| CITADEL ADVISORS LLC | 0.4% | 168,344 | +56% | 0% | $755,864 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
31
Latest
Q2 2026
Rows shown
1-25 of 31
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 21,305,178 | $95,653,830 | +$2,373,825 | $4.49 | 68 |
| 2026 Q1 | 20,809,791 | $76,784,547 | +$5,515,763 | $3.69 | 67 |
| 2025 Q4 | 19,119,856 | $66,915,648 | +$11,936,562 | $3.50 | 59 |
| 2025 Q3 | 15,737,051 | $33,674,427 | -$213,867 | $2.14 | 47 |
| 2025 Q2 | 15,811,115 | $35,574,319 | +$288,225 | $2.25 | 39 |
| 2025 Q1 | 15,792,917 | $21,635,134 | -$202,681 | $1.37 | 43 |
| 2024 Q4 | 15,925,107 | $25,160,336 | +$4,988,209 | $1.58 | 45 |
| 2024 Q3 | 12,800,031 | $15,871,504 | -$371,477 | $1.24 | 45 |
| 2024 Q2 | 13,089,462 | $17,538,939 | -$313,631 | $1.34 | 49 |
| 2024 Q1 | 13,334,937 | $18,134,845 | -$10,597,896 | $1.36 | 51 |
| 2023 Q4 | 17,452,702 | $45,730,029 | -$5,190,379 | $2.62 | 62 |
| 2023 Q3 | 18,328,200 | $58,651,537 | -$229,028 | $3.20 | 61 |
| 2023 Q2 | 18,770,221 | $94,412,555 | -$2,505,631 | $5.03 | 55 |
| 2023 Q1 | 20,085,109 | $58,156,535 | +$5,918,433 | $2.88 | 54 |
| 2022 Q4 | 18,191,340 | $42,568,844 | -$7,872,047 | $2.34 | 48 |
| 2022 Q3 | 20,926,665 | $93,963,141 | -$1,016,635 | $4.49 | 53 |
| 2022 Q2 | 21,031,854 | $123,244,150 | +$8,066,381 | $5.86 | 61 |
| 2022 Q1 | 19,582,685 | $127,931,812 | -$1,520,009 | $6.53 | 70 |
| 2021 Q4 | 19,106,864 | $244,910,256 | -$2,633,464 | $12.82 | 74 |
| 2021 Q3 | 18,881,855 | $261,278,213 | +$1,837,936 | $13.85 | 74 |
| 2021 Q2 | 19,074,530 | $196,570,403 | +$519,685 | $10.31 | 73 |
| 2021 Q1 | 18,975,246 | $183,295,913 | +$4,233,889 | $9.66 | 67 |
| 2020 Q4 | 18,563,287 | $133,715,214 | +$4,919,670 | $7.20 | 63 |
| 2020 Q3 | 17,818,092 | $83,924,627 | -$799,192 | $4.71 | 59 |
| 2020 Q2 | 18,132,429 | $100,699,990 | +$1,987,743 | $5.55 | 60 |